1 documents found
Information × Registration Number 0210U006519, 0109U005336 , R & D reports Title Investigation of the role of dopamine and DOPAMINE D2 receptors in the pathogenesis of inflammatory bowel disease because of its role in VEGFNPF-vascular permeability caused by the large intestine. popup.stage_title Head Tolstanova Ganna Mykolayvna, Registration Date 27-09-2010 Organization Taras Shevchenko Kiev university popup.description2 Shown lower expression of tyrosine hidroksylazy, DOPAMINE conveyer DAT they increase DOPAMINE D2 receptor expression in experimental models of inflammatory bowel diseases. DOPAMINE D2 receptor activation likely improved morphological yodoatsetamid-induced colitis in rats, depressed pronykist vascular mucosa of colon and decreasing mizhbilkovu interaction between beta-arrestynom2 and VE-cadherin and reduced activity of Akt. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Investigation of the role of dopamine and DOPAMINE D2 receptors in the pathogenesis of inflammatory bowel disease because of its role in VEGFNPF-vascular permeability caused by the large intestine.
Head: Tolstanova Ganna Mykolayvna. Investigation of the role of dopamine and DOPAMINE D2 receptors in the pathogenesis of inflammatory bowel disease because of its role in VEGFNPF-vascular permeability caused by the large intestine.. (popup.stage: ). Taras Shevchenko Kiev university. № 0210U006519
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку